#United States #San Francisco #AI Platform #Inc. 5000 #SamaCare

SamaCare Marks a Significant Milestone in the Inc. 5000 Ranking

SamaCare, an innovative platform utilizing artificial intelligence for medical benefit prior authorizations, has achieved the remarkable distinction of being ranked No. 1021 on the 2026 Inc. 5000 list. This recognition not only places the company in the top 25% of the fastest-growing private firms in the United States but does so for the third consecutive year.

The continued success of SamaCare is indicative of the increasing demand for technology that diminishes the administrative hurdles separating prescriptions and the initiation of treatment. Over the last year, the company has introduced several enhancements to its AI-driven prior authorization platform, launched a novel insights solution tailored for life sciences market access teams, and rolled out industry-first Market Access Benchmarks to track performance in medical benefit prior authorizations.

According to Syam Palakurthy, Founder and CEO of SamaCare, this accolade symbolizes more than mere recognition; it's a reflection of the critical issues the firm is addressing within the healthcare sector. He stated, "Specialty practices encounter increasingly complicated payer regulations, while life sciences teams seek greater transparency concerning access obstacles that can determine if patients commence and remain on therapy. Our growth underscores the urgency of this necessity and our unwavering commitment to employing AI and workflow automation to assist patients in receiving their prescribed treatments."

SamaCare's platform stands out by providing a cohesive workflow for prior authorizations covering provider-administered specialty medications that span diverse payers and plans. By integrating automation, intelligence pertaining to payer policies, insightful workflow data, and AI-generated analytics, SamaCare significantly alleviates the administrative burdens faced by practices, granting life sciences teams a better understanding of the access challenges difficult to discern through traditional claims or hub data alone.

In 2026, the launch of Market Access Benchmarks marked a pivotal moment, being the first publicly available benchmarks dedicated to assessing medical benefit prior authorization performance. These benchmarks offer critical quarterly insights into net approval rates and resolution durations for medical benefit drugs. This data equips market access, patient services, and provider engagement teams with a nuanced understanding of where access challenges arise and where strategic interventions could enhance patient treatment initiations.

Moreover, SamaCare has consistently expanded its insights products for market access teams. This empowers life sciences organizations to detect barriers at the payer, provider, specialty, and workflow levels that could hinder therapy uptake. Such insights enable teams to move past outdated metrics, allowing them to grasp the real-world administrative pathways that patients and providers encounter after a therapy is prescribed.

In reflecting on the achievement, Mike Hofman, the editor-in-chief of Inc. monthly, expressed, "Every company on the Inc. 5000 embodies a narrative of resilience, strategic decision-making, and a relentless pursuit of progress. Their growth signifies not merely strong financial performance but also reflects the innovation, resilience, and customer-centric approach essential for creating companies with a lasting impact. Congratulations to all honorees on this remarkable success."

For those interested in the complete Inc. 5000 list, including profiles of honorees and an industry-and-location-specific searchable database, more information can be found at www.inc.com/inc5000.

About SamaCare

SamaCare is an AI-driven insights and interventions platform that aims to expedite patient access to specialized therapies by streamlining the prior authorization process for provider-managed medications. The platform compiles and assesses real-world data from millions of prior authorizations through a national provider network, delivering actionable insights and in-workflow support that minimize delays, reject decisions, and abandonment of therapy. SamaCare collaborates with pharmaceutical manufacturers, healthcare providers, and patient access teams to enhance the journey from prescription to therapy commencement. For further details, visit www.samacare.com.